Cronos (CRON) Share-based Compensation (2019 - 2026)
Cronos (CRON) recorded quarterly Share-based Compensation of $1.3 million in Q1 2026, up 5.21% quarter-over-quarter from $1.2 million in Q4 2025, and down 37.12% on a YoY basis from $2.1 million in Q1 2025.
Cronos (CRON) Share-based Compensation (2019 - 2026) Analysis & Trends
Cronos' Share-based Compensation history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Share-based Compensation fell 37.12% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $6.3 million (down 28.47% YoY), while the FY2025 annual figure was $7.0 million, down 18.97% from the prior year.
- Share-based Compensation was $1.3 million for Q1 2026 at Cronos, up from $1.2 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $4.5 million in Q4 2022 to a low of $1.2 million in Q4 2025.
- Historically, Share-based Compensation has averaged $2.4 million across 5 years, with a median of $2.2 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation jumped 87.93% in 2022, then tumbled 57.59% in 2023.
- A 5-year view of Share-based Compensation shows it stood at $4.5 million in 2022, then sank by 57.59% to $1.9 million in 2023, then increased by 13.37% to $2.2 million in 2024, then tumbled by 42.94% to $1.2 million in 2025, then increased by 5.21% to $1.3 million in 2026.
- The last three Share-based Compensation figures came in at $1.3 million (Q1 2026), $1.2 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn | 1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 2.09 Mn |
| Mar 31, 2025 | 2.09 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Sep 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 2.24 Mn |
| Jun 30, 2024 | 2.24 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Dec 31, 2023 | 1.93 Mn |